| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of mistaken identity? Vaccinia virus in a live camelpox vaccine
|
Yousif, A.A.
|
|
2012
|
40 |
6 |
p. 495-498
4 p.
|
artikel
|
| 2 |
Aims and Scope/Editorial Board/Publishing Details
|
|
|
2012
|
40 |
6 |
p. IFC-
1 p.
|
artikel
|
| 3 |
Anamnestic immunological response profile in laboratory animals after immunization with recombinant hepatitis B vaccines of different generations
|
Górska, Paulina
|
|
2012
|
40 |
6 |
p. 431-438
8 p.
|
artikel
|
| 4 |
Collaborative study to establish a proficiency panel of hepatitis B surface antigens for evaluating in vitro diagnostics
|
Wang, Kun-Teng
|
|
2012
|
40 |
6 |
p. 445-450
6 p.
|
artikel
|
| 5 |
Comparability studies of new 3rd generation recombinant human factor VIII GreenGene F after improvement of formulation and viral inactivation/removal process
|
Paik, Sang Hoon
|
|
2012
|
40 |
6 |
p. 405-414
10 p.
|
artikel
|
| 6 |
Detection of RD-114 virus by a reverse transcriptase assay based on product enhancement
|
Narushima, Rie
|
|
2012
|
40 |
6 |
p. 421-425
5 p.
|
artikel
|
| 7 |
Development and preliminary validation of an antibody filtration-assisted single-dilution chemiluminometric immunoassay for potency testing of Piscirickettsia salmonis vaccines
|
Wilda, Maximiliano
|
|
2012
|
40 |
6 |
p. 415-420
6 p.
|
artikel
|
| 8 |
Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies
|
Simões, Marisol
|
|
2012
|
40 |
6 |
p. 399-404
6 p.
|
artikel
|
| 9 |
Evaluation of an in vitro assay system as a potential alternative to current histamine sensitization test for acellular pertussis vaccines
|
Xing, Dorothy
|
|
2012
|
40 |
6 |
p. 456-465
10 p.
|
artikel
|
| 10 |
Evaluation of tumorigenic potential of high yielding cloned MDCK cells for live-attenuated influenza vaccine using in vitro growth characteristics, metastatic gene expression and in vivo nude mice model
|
Vepachedu, Ramarao S.
|
|
2012
|
40 |
6 |
p. 482-494
13 p.
|
artikel
|
| 11 |
Health Canada/BIOTECanada Summit on regulatory and clinical topics related to subsequent entry biologics (biosimilars), Ottawa, Canada, 14 May 2012
|
Kay, Jonathan
|
|
2012
|
40 |
6 |
p. 517-527
11 p.
|
artikel
|
| 12 |
In vitro antigen ELISA for quality control of tetanus vaccines
|
Coombes, Laura
|
|
2012
|
40 |
6 |
p. 466-472
7 p.
|
artikel
|
| 13 |
Potency estimation of vaccine batches remains unaffected by anesthesia for intracerebral injection
|
Kamphuis, Elisabeth
|
|
2012
|
40 |
6 |
p. 451-455
5 p.
|
artikel
|
| 14 |
Sequence analysis of capsid coding region of foot-and-mouth disease virus type A vaccine strain during serial passages in BHK-21 adherent and suspension cells
|
Anil, K.U.
|
|
2012
|
40 |
6 |
p. 426-430
5 p.
|
artikel
|
| 15 |
Statistical evaluations of viral clearance studies for biological products
|
Li, Na
|
|
2012
|
40 |
6 |
p. 439-444
6 p.
|
artikel
|
| 16 |
The WHO network of collaborating centres on standardization and regulatory evaluation of vaccines
|
Knezevic, Ivana
|
|
2012
|
40 |
6 |
p. 499-506
8 p.
|
artikel
|
| 17 |
Virus safety of plasma products using 20 nm instead of 15 nm filtration as virus removing step
|
Koenderman, A.H.L.
|
|
2012
|
40 |
6 |
p. 473-481
9 p.
|
artikel
|
| 18 |
WHO/Health Canada meeting on regulatory considerations for evaluation and licensing of new meningococcal Group B vaccines, Ottawa, Canada, 3–4 October 2011
|
Feavers, Ian
|
|
2012
|
40 |
6 |
p. 507-516
10 p.
|
artikel
|
Tijdschrift beschrijving